Mathematical modeling of an immune checkpoint inhibitor and its synergy with an immunostimulant
From MaRDI portal
Publication:2033441
Recommendations
- A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor
- Mathematical model for delayed responses in immune checkpoint blockades
- Cancer therapy with immune checkpoint inhibitor and CSF-1 blockade: a mathematical model
- Mathematical modeling and dynamic analysis of anti-tumor immune response
- A mathematical model of tumor-immune interactions
- Mathematical modeling for tumor-immune interaction
- Mathematical modeling of tumor-immune cell interactions
- Mathematical models of therapeutical actions related to tumour and immune system competition
- A mathematical model of cancer treatment by immunotherapy
- Mathematical and numerical modelling of interference of immune cells in the tumour environment
Cites work
- A comparison and catalog of intrinsic tumor growth models
- A trust region method based on interior point techniques for nonlinear programming.
- Dynamics analysis of a predator-prey system with harvesting prey and disease in prey species
- Estimating tumor growth rates in vivo
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Patient-specific parameter estimates of glioblastoma multiforme growth dynamics from a model with explicit birth and death rates
- Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
Cited in
(42)- Developing a minimally structured mathematical model of cancer treatment with oncolytic viruses and dendritic cell injections
- A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy
- Dynamics of immune checkpoints, immune system, and BCG in the treatment of superficial bladder cancer
- Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of BCG treatment of bladder cancer
- Computation of the conditions for anti-angiogenesis and gene therapy synergistic effects: sensitivity analysis and robustness of target solutions
- Mathematical modeling of tumor growth and treatment: triple negative breast cancer
- Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy
- A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies
- Cancer therapy with immune checkpoint inhibitor and CSF-1 blockade: a mathematical model
- Dynamic analysis of a model on tumor-immune system with regulation of PD-1/PD-L1 and stimulation delay of tumor antigen
- Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer
- Mathematical modeling, analysis, and simulation of tumor dynamics with drug interventions
- A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor
- Modelling of killer T-cell and cancer cell subpopulation dynamics under immuno- and chemotherapies
- Mathematical modeling of cancer treatment with radiation and PD-L1 inhibitor
- Response of patients with melanoma to immune checkpoint blockade -- insights gleaned from analysis of a new mathematical mechanistic model
- Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors
- On modeling the synergy of cancer immunotherapy with radiotherapy
- Stability and Hopf bifurcation of a tumor-immune system interaction model with an immune checkpoint inhibitor
- A feedback control model of comprehensive therapy for treating immunogenic tumours
- In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach
- A Delayed Dynamical Model Describing the Effect of Tumor-Induced Vascular Endothelial Growth Factor on Angiogenesis: Backward Bifurcations and Global Dynamics
- A prognostic immunotherapy model for 4T1 breast cancer with combined cyclophosphamide and TLR agonist
- Combination therapy for cancer with IL-27 and anti-PD-1: A simplified mathematical model
- Bifurcation Analysis in a Tumor-Immune System Interaction Model with Dendritic Cell Therapy and Immune Response Delay
- Analysis of tumor-immune functional responses in a mathematical model of neoantigen cancer vaccines
- Investigating the synergistic effects of immunotherapy and normalization treatment in modulating tumor microenvironment and enhancing treatment efficacy
- Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma
- Investigating tumor-host response dynamics in preclinical immunotherapy experiments using a stepwise mathematical modeling strategy
- Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study
- Bifurcations of a cancer immunotherapy model explaining the transient delayed response and various other responses
- Cytokine storm mitigation for exogenous immune agonists
- Mathematical modeling of tumor immune interactions: the role of anti-FGFR and anti-PD-1 in the combination therapy
- Predicting resistance and pseudoprogression: are minimalistic immunoediting mathematical models capable of forecasting checkpoint inhibitor treatment outcomes in lung cancer?
- Mathematical modeling and solution landscape reveal cancer progression dynamics in tumor ecological microenvironment
- Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model
- PULSAR effect: revealing potential synergies in combined radiation therapy and immunotherapy via differential equations
- Mathematical modeling of Allee effects in tumor dynamics: insights into chemotherapy and immunotherapy optimization
- Bifurcation analysis of tumor-immune dynamics under the dual Allee effects
- Modeling combination therapies and T cell exhaustion dynamics in the tumor under immune checkpoint blockade
- Existence, stability and optimal drug dosage for a reaction-diffusion system arising in a cancer treatment
- Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
This page was built for publication: Mathematical modeling of an immune checkpoint inhibitor and its synergy with an immunostimulant
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2033441)
